ICU Medical Debt to Equity Ratio 2010-2025 | ICUI
Current and historical debt to equity ratio values for ICU Medical (ICUI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. ICU Medical debt/equity for the three months ending March 31, 2025 was 0.75.
| ICU Medical Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $2.20B | $1.99B | 1.11 |
| 2024-12-31 | $2.24B | $1.97B | 1.14 |
| 2024-09-30 | $2.26B | $2.05B | 1.10 |
| 2024-06-30 | $2.25B | $2.04B | 1.10 |
| 2024-03-31 | $2.22B | $2.07B | 1.07 |
| 2023-12-31 | $2.26B | $2.12B | 1.06 |
| 2023-09-30 | $2.28B | $2.10B | 1.09 |
| 2023-06-30 | $2.35B | $2.12B | 1.11 |
| 2023-03-31 | $2.37B | $2.10B | 1.13 |
| 2022-12-31 | $2.43B | $2.09B | 1.16 |
| 2022-09-30 | $2.44B | $2.01B | 1.21 |
| 2022-06-30 | $2.50B | $2.09B | 1.20 |
| 2022-03-31 | $2.57B | $2.18B | 1.18 |
| 2021-12-31 | $0.27B | $1.62B | 0.16 |
| 2021-09-30 | $0.25B | $1.59B | 0.16 |
| 2021-06-30 | $0.25B | $1.56B | 0.16 |
| 2021-03-31 | $0.24B | $1.52B | 0.16 |
| 2020-12-31 | $0.26B | $1.50B | 0.17 |
| 2020-09-30 | $0.28B | $1.45B | 0.19 |
| 2020-06-30 | $0.45B | $1.41B | 0.32 |
| 2020-03-31 | $0.44B | $1.38B | 0.32 |
| 2019-12-31 | $0.32B | $1.38B | 0.23 |
| 2019-09-30 | $0.30B | $1.34B | 0.22 |
| 2019-06-30 | $0.31B | $1.32B | 0.23 |
| 2019-03-31 | $0.33B | $1.28B | 0.26 |
| 2018-12-31 | $0.32B | $1.26B | 0.26 |
| 2018-09-30 | $0.29B | $1.26B | 0.23 |
| 2018-06-30 | $0.27B | $1.26B | 0.21 |
| 2018-03-31 | $0.26B | $1.23B | 0.21 |
| 2017-12-31 | $0.30B | $1.20B | 0.25 |
| 2017-09-30 | $0.38B | $1.14B | 0.33 |
| 2017-06-30 | $0.37B | $1.12B | 0.33 |
| 2017-03-31 | $0.33B | $1.14B | 0.29 |
| 2016-12-31 | $0.05B | $0.66B | 0.07 |
| 2016-09-30 | $0.04B | $0.65B | 0.06 |
| 2016-06-30 | $0.05B | $0.62B | 0.08 |
| 2016-03-31 | $0.04B | $0.60B | 0.07 |
| 2015-12-31 | $0.05B | $0.58B | 0.08 |
| 2015-09-30 | $0.04B | $0.57B | 0.08 |
| 2015-06-30 | $0.03B | $0.54B | 0.06 |
| 2015-03-31 | $0.04B | $0.52B | 0.07 |
| 2014-12-31 | $0.03B | $0.51B | 0.07 |
| 2014-09-30 | $0.04B | $0.49B | 0.07 |
| 2014-06-30 | $0.03B | $0.49B | 0.07 |
| 2014-03-31 | $0.03B | $0.47B | 0.07 |
| 2013-12-31 | $0.04B | $0.47B | 0.08 |
| 2013-09-30 | $0.04B | $0.43B | 0.08 |
| 2013-06-30 | $0.04B | $0.42B | 0.09 |
| 2013-03-31 | $0.03B | $0.40B | 0.09 |
| 2012-12-31 | $0.04B | $0.39B | 0.10 |
| 2012-09-30 | $0.04B | $0.37B | 0.11 |
| 2012-06-30 | $0.04B | $0.35B | 0.12 |
| 2012-03-31 | $0.04B | $0.34B | 0.11 |
| 2011-12-31 | $0.04B | $0.32B | 0.13 |
| 2011-09-30 | $0.04B | $0.31B | 0.12 |
| 2011-06-30 | $0.04B | $0.31B | 0.13 |
| 2011-03-31 | $0.04B | $0.29B | 0.14 |
| 2010-12-31 | $0.04B | $0.27B | 0.14 |
| 2010-09-30 | $0.04B | $0.26B | 0.15 |
| 2010-06-30 | $0.04B | $0.25B | 0.17 |
| 2010-03-31 | $0.04B | $0.25B | 0.17 |
| 2009-12-31 | $0.04B | $0.27B | 0.17 |
| 2009-09-30 | $0.03B | $0.28B | 0.12 |
| 2009-06-30 | $0.03B | $0.27B | 0.11 |
| 2009-03-31 | $0.03B | $0.26B | 0.13 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.341B | $2.382B |
| ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| LeMaitre Vascular (LMAT) | United States | $1.910B | 42.70 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |